Health Condition 1: I828- Embolism and thrombosis of other specified veins
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Provoked DVT Radioimaging confirmed acute DVT Informed consent from guardian
Exclusion criteria
Exclusion criteria: Prior VTE Active malignancy SLE or any rheumatological condition Planned thrombolysis Major thrombophilia Active bleeding or high bleeding risk or platelet count less than 50000 Severe hepatic or renal dysfunction Refusal of consent Ongoing risk factor requiring prolonged anticoagulation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage reduction in thrombus size from baseline Complete vs partial vs no resolution Timepoint: Percentage reduction in thrombus size from baseline Complete vs partial vs no resolution at 6 week and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of new thrombotic events during treatment and up to 6 months post therapy confirmed by USG Bleeding Episodes using International Society on Thrombosis and Haemostasis criteria Post-Thrombotic Syndrome measured using Modified Villalta ScoreTimepoint: At 6 months monthly follow up after therapy | — |
Countries
India
Contacts
Atal Bihari Vajpayee Institute of Medical Sciences and Dr Ram Manohar Lohia Hospital